SCI时时刷

search
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
Localized prostate cancer (PCa) is a largely heterogeneous disease regarding its clinical behavior. Current risk stratific...
Prostatic stents: a systematic review and analysis of functional outcomes and complication rate
Prostatic stents: a systematic review and analysis of functional outcomes and complication rate
This review aims to identify and summarize the current literature on the use of prostatic stents or nitinol devices as min...
Prostate cancer detection: achieving an optimal balance
The U.S. Food and Drug Administration (FDA) approved the serum PSA test in 1986 for monitoring prosta...
Overcoming barriers to prostate cancer genetic testing: who, when, and how
Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjord JE, et al. BRCA2 mutation in Icelandic...
Undetected Cribriform and Intraductal Prostate Cancer at biopsy is associated with adverse outcomes
Undetected Cribriform and Intraductal Prostate Cancer at biopsy is associated with adverse outcomes
Intraductal carcinoma (IDC) and cribriform pattern (Crib) of prostate cancer are increasingly recognized as independent pr...
Identifying the best candidate for focal therapy: a comprehensive review
Identifying the best candidate for focal therapy: a comprehensive review
Despite the evidence supporting the use of focal therapy (FT) in patients with localized prostate cancer (PCa), considerab...
Established focal therapy—HIFU, IRE, or cryotherapy—where are we now?—a systematic review and meta-analysis
Established focal therapy—HIFU, IRE, or cryotherapy—where are we now?—a systematic review and meta-analysis
Focal Therapy (FT) is a treatment option for the treatment of limited volume clinically significant prostate cancer (csPCa...
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Novel therapies for metastatic castration-resistant prostate cancer (mCRPC) have improved patient outcomes. However, there...
Surveillance after Focal Therapy – a Comprehensive Review
Surveillance after Focal Therapy – a Comprehensive Review
to date, no standardized, evidence-based follow-up schemes exist for the monitoring of patients who underwent focal therap...
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)
Unfortunately, not all metastatic castration resistant prostate cancer (mCRPC) patients receive available life-prolonging ...
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)
Unfortunately, not all metastatic castration-resistant prostate cancer (mCRPC) patients receive available life-prolonging ...
Prostate cancer in low- and middle-income countries - challenges and opportunities
James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for t...
Trends in pre-biopsy MRI usage for prostate cancer detection, 2007–2022
Trends in pre-biopsy MRI usage for prostate cancer detection, 2007–2022
Clinical guidelines favor MRI before prostate biopsy due to proven benefits. However, adoption patterns across the US are ...
The changing face of castrate resistant prostate cancer
Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, et al. Docetaxel and estramustine compared with mitox...
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer
Staging patients with high-risk prostate cancer (HRPCa) with conventional imaging of computed tomography (CT) and bone sci...
Ejaculatory function after radiotherapy for prostate cancer: a systematic review and meta-analysis
Ejaculatory function after radiotherapy for prostate cancer: a systematic review and meta-analysis
Scant data exists on the impacts of prostate radiation on ejaculatory function. We performed a systematic review and meta-...